申请人:DUPHAR INTERNATIONAL RESEARCH B.V
公开号:EP0338650A1
公开(公告)日:1989-10-25
The invention relates to new imidazolylmethyl-cycloalkane[b]indolones having formula
wherein
- R₀ is alkyl or alkoxy having 1-4 C-atoms, hydroxy, halogen, trifluoromethyl, a group R₆R₇N or R₆R₇-N-CO, wherein R₆ and R₇ are hydrogen or alkyl having 1-4 C-atoms or wherein R₆R₇N is a saturated 5-6 ring and n has the value 0, 1 or 2,
- R₁ is hydrogen, 1-8 C alkyl, 3-7 C cycloalkyl, 3-7 C cycloalkyl-(1-3 C)- alkyl, 3-6 C alkenyl, 3-8 C alkynyl, phenyl or phenyl-(1-3 C) alkyl, wherein the phenyl group may be substituted with one or more alkyl groups, alkoxy groups or OH-groups or with one or more halogen atoms, or R₁ is a group COOR₈, COR₈, SO₂R₈, wherein R₈ is 1-4 C alkyl, 3-7 C cycloalkyl, phenyl or phenyl-(1-2 C)alkyl wherein the phenyl group may be substituted with one or more 1-4 C alkyl groups, 1-4 C alkoxy groups, hydroxyl groups or halogen atoms, or R₁ is a group R₉R₁₀N-C ⁰ wherein R₉ and R₁₀ independently of each other are hydrogen, 1-4 C alkyl, phenyl or phenyl-(1-2 C)alkyl wherein the phenyl group may be substituted, or wherein R₉ and R₁₀ together with the nitrogen atom to which they are bound constitute a saturated 5-6 ring,
- one of the groups R₂, R₃ and R₄ is hydrogen, alkyl having 1-4 C atoms, cycloalkyl having 3-6 C-atoms, alkenyl having 2-4 C-atoms or phenyl-alkyl having 1-2 C-atoms in the alkyl group and the two other groups, independently of each other, are hydrogen or alkyl having 1-4 C-atoms,
- m has the value 3 to 8 inclusive,
and the pharmaceutically acceptable acid addition salts thereof.
The compounds have a longer-lasting selective antagonistic activity on "neuronal" 5-hydroxytryptamine (5-HT) receptors as compared with related known compounds, and they are less toxic.
该发明涉及新的咪唑基甲基-环烷[b]吲哚酮类化合物,其化学式为:其中,- R₀是具有1-4个碳原子的烷基或烷氧基,羟基,卤素,三氟甲基,R₆R₇N或R₆R₇-N-CO基团,其中R₆和R₇是氢或具有1-4个碳原子的烷基,或者R₆R₇N是饱和的5-6环,n的值为0,1或2,- R₁是氢,1-8个碳原子的烷基,3-7个碳原子的环烷基,3-7个碳原子的环烷基-(1-3个碳原子)-烷基,3-6个碳原子的烯基,3-8个碳原子的炔基,苯基或苯基-(1-3个碳原子)烷基,其中苯基可以被一个或多个烷基,烷氧基或羟基取代,或者被一个或多个卤素原子取代,或者R₁是COOR₈,COR₈,SO₂R₈基团,其中R₈是1-4个碳原子的烷基,3-7个碳原子的环烷基,苯基或苯基-(1-2个碳原子)烷基,其中苯基可以被一个或多个1-4个碳原子的烷基,1-4个碳原子的烷氧基,羟基或卤素原子取代,或者R₁是R₉R₁₀N-C ⁰基团,其中R₉和R₁₀彼此独立地是氢,1-4个碳原子的烷基,苯基或苯基-(1-2个碳原子)烷基,其中苯基可以被取代,或者R₉和R₁₀连同它们所结合的氮原子构成饱和的5-6环,- R₂,R₃和R₄中的一个是氢,具有1-4个碳原子的烷基,具有3-6个碳原子的环烷基,具有2-4个碳原子的烯基或具有1-2个碳原子的苯基-烷基,而另外两个基团独立地是氢或具有1-4个碳原子的烷基,- m的值为3到8,包括8,并且其药学上可接受的酸盐。这些化合物与相关已知化合物相比具有更持久的选择性拮抗“神经元”5-羟色胺(5-HT)受体的活性,并且毒性更低。